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Gammaretrovirusesofseveraldiﬀerenthostrangesubgroupshavebeenisolatedfromlaboratorymice.Theecotropicvirusesinfect
mouse cells and rely on the host CAT-1 receptor. The xenotropic/polytropic viruses, and the related human-derived XMRV, can
infect cells of other mammalian species and use the XPR1 receptor for entry. The coevolution of these viruses and their receptors
in infected mouse populations provides a good example of how genetic conﬂicts can drive diversifying selection. Genetic and
epigeneticvariationsinthevirusenvelopeglycoproteinscanresultinalteredhostrangeandpathogenicity,andchangesinthevirus
binding sites of the receptors are responsible for host restrictions that reduce virus entry or block it altogether. These battleground
regions are marked by mutational changes that have produced 2 functionally distinct variants of the CAT-1 receptor and 5 variants
of the XPR1 receptor in mice, as well as a diverse set of infectious viruses, and several endogenous retroviruses coopted by the host
to interfere with entry.
1.Introduction
The various inbred strains of laboratory mice and wild
mouse species diﬀer in their susceptibility to mouse gam-
maretrovirus infection and to virus-induced diseases. Host
resistanceisduetonumerousconstitutivelyexpressedantivi-
ralfactorsthattargetspeciﬁcstagesoftheretrovirallifecycle.
These host restriction factors can block entry, postentry
uncoating and reverse transcription, traﬃcking, integration,
assembly,andrelease[1].Theﬁrststepinthereplicativecycle
is entry, and this process relies on host-encoded receptors.
Host cell factors that can interfere with virus entry include
genetic variations of the cell receptor as well as other host
factors such as envelope (Env) glycoproteins produced by
endogenous retroviruses (ERVs).
Infectious mouse leukemia viruses (MLVs) of three
subgroups have been isolated from laboratory mice, and
these subgroups were initially deﬁned by their species
tropisms. The ecotropic MLVs (E-MLVs) infect only mouse
or rat cells and use the amino acid transporter CAT-1 as
receptor.ThexenotropicMLVs(X-MLVs)infectcellsofnon-
rodent species [2], and polytropic MLVs (P-MLVs) infect
both mouse and non-rodent cells [3, 4]. The X-MLVs and
P-MLVs together constitute the XP-MLVs and both use the
XPR1 receptor [5–8].
Receptor choice is determined by the N-terminal portion
of the MLV Env, the receptor-binding domain (RBD) [9–
11]. The E-MLVs and XP-MLVs both have Env subtypes
that diﬀer in their ability to use polymorphic variants
of their cognate receptors, and some of these host-range
variants, the “xenotropic” MLVs, are completely restricted in
mouse cells [12]. Both receptors for the laboratory mouse
MLVs, CAT-1 and XPR1, have naturally occurring variants
responsible for speciﬁc virus resistance phenotypes. There
are 2 functionally distinct variants of the CAT-1 receptor
for E-MLVs [13], and there are 5 known variants of the
XPR1 receptor for the XP-MLVs in mice [5, 14–17]. These
variants are not only important host factors that can restrict
infection, but also they can alter virus-receptor interactions
in ways that inﬂuence virus-induced pathology. This paper2 Advances in Virology
willdescribethefunctionalvariantsofthese2MLVreceptors
and describe their coevolution with MLV in virus-infected
mouse populations.
2. The CAT-1 Receptor for E-MLVs
The ﬁrst gammaretrovirus receptor gene to be cloned was
the CAT-1 receptor for E-MLVs [18]. This gene (gene
symbol Slc7a1) encodes a glycoprotein with 14 putative
transmembrane domains, and it functions as a cationic
amino acid transporter [19, 20]( Figure 1(a)). Ten additional
gammaretrovirus receptors have now been cloned; all of
these gammaretrovirus receptors are multi-transmembrane
proteins, and the receptors with known functions are all
transporters of small solutes (reviewed in [21–26]). The
human orthologue of mouse CAT-1 does not function as
an E-MLV receptor, and the key sites in the mouse protein
critical for virus entry lie in the third extracellular loop
along with two consensus recognition sites for N-linked
glycosylation [27, 28] (Figures 1(a) and 1(b)). CAT-1 is
modiﬁed posttranslationally by glycosylation, and N-glycans
areaddedtobothoftheCAT-1loop3glycosylationsites[29].
All E-MLVs rely on the CAT-1 receptor for entry, although
initial binding and the eﬃciency of entry may be inﬂuenced
by other factors at the cell surface, such as heparin [30, 31].
The E-MLV Env glycoprotein consists of surface (SU)
and transmembrane (TM) subunits that are proteolytically
cleaved from the same precursor protein and are linked by
disulﬁde bonds. The SU protein has a 236 residue RBD
at its N-terminal end that has 3 variable regions, and
this is followed by a proline-rich hinge region and a C-
terminal domain (Figure 2(a)). Entry is initiated by virus-
receptorbinding whichprecipitatesaconformationalchange
in Env that allows for subsequent fusion of viral and cellular
membranes, a process that may involve cellular proteases
[32]. The CAT-1 receptor recognition site is within the ﬁrst
variable domain (VRA) of the RBD. Three residues within
the RBD VRA of the Friend E-MLV, FrMLV, have been
identiﬁed as critical for entry (S84, D86, and W102) [33–35].
The crystal structure and functional analysis of the FrMLV
RBDshowedthattheseresiduesformabindingpocketonthe
structure’s surface [35, 36]( Figure 2(b)). Several additional
Env residues outside the binding pocket aﬀect postbinding
entry. Thus, the H8 residue in a conserved SPHQV motif
near the SU N-terminus is necessary for fusion [37, 38]
although residues at the other end of the MoMLV RBD, at
positions 227 and 243 (equivalent to FrMLV sites 229 and
245), can substitute for H8 [39]. The proline-rich region
is also involved in mediating postbinding conformational
changes and fusion [40], and residues in two segments of
the C-terminus of Env also have roles in fusion [41–43]
(Figure 2(a)).
3. Variants of the CAT-1 Receptor and E-MLV
EnvAffect VirusEntry
There has been no systematic attempt to screen for CAT-
1 receptor variation in mice, but 3 sequence variants have
beenidentiﬁedinMus (Figure 1(b)).Theprototypereceptor,
mCAT-1, was cloned from NIH 3T3 cells [18]. Two sequence
variants have been identiﬁed in the wild mouse species
M. dunni and M. minutoides [13, 44]. Limited testing
suggests that the M. minutoides CAT-1 functions like the
laboratory mouse mCAT-1 receptor, but the receptor of
M. dunni, dCAT-1, diﬀers from mCAT-1. M. dunni cells
are relatively resistant to infection by Moloney E-MLV
(MoMLV), although these cells are fully susceptible to other
E-MLV isolates [13]. dCAT-1 diﬀers from mCAT-1 by 4
residues, two of which are in the receptor determining third
extracellular loop; one, I214V, is a substitution, and the
second is a glycine insertion within the NVKYGE virus
binding site [13]( Figure 1(b)).
Two mutational changes in the MoMLV RBD VRA
independently produce viruses that eﬃciently infect M.
dunni cells: a replacement mutation, S82F, and introduction
of two serine residues that are present in other E-MLV VRAs
but absent in MoMLV (S76, S77 in FrMLV) (Figure 2(a))
[45]. The MoMLV S82F mutation site corresponds to S84 in
Friend MLV, one of the 3 residues critical for virus binding
and entry. The importance of this residue for virus tropism
is underscored by the fact that MoMLV-S82F is poorly
infectious in cells that carry mCAT-1 [45]( Figure 1(b)).
E-MLVs can infect rodent species in addition to Mus,
andCAT-1receptorvariantshavebeendescribedinhamsters
and rats (Figure 1(b)). Hamster cells are generally resistant
to infection by E-MLVs, but some variants of FrMLV can
infect these cells [46]. Infectivity of one such variant, PVC-
211, was attributed to Env substitutions E116G and E129K
[47]( Figure 2). Another FrMLV variant, F-S MLV, also
ineﬃciently but reproducibly infects hamster cells; it was
suggested that this tropism was inﬂuenced by two substitu-
tions: S84A and S79N [48]. Restriction of some E-MLVs can
result from complementary changes in the interacting sites
of virus Env and the CAT-1 receptor; however, the MoMLV
restriction associated with dCAT-1 is reproduced in human
cells expressing this receptor [13], but not in ferret cells
[49], suggesting that other cellular factors may also inﬂuence
receptor function.
4.CAT-1 andEnvPolymorphisms Associated
with Pathogenicity
Polymorphisms that alter virus-receptor interactions can
aﬀect pathogenesis as well as entry. Cytopathic variants are
common among the retroviruses that induce disease in their
hosts, including HIV-1 as well as avian leukosis viruses
and some pathogenic bovine and feline leukemia viruses
[50–52]. These viruses can produce large multinucleated
syncytia in cultures of susceptible cells. In contrast, mouse
gammaretroviruses rarely produce syncytia although there
are three exceptional cytopathic E-MLVs. The MoMLV
variant, Spl574 and a FrMLV variant, F-S MLV, both induce
syncytia and cell death in M. dunni cells [45, 48]. The third
cytopathic virus, TR1.3, is a neuropathic FrMLV variant that
also induces syncytia in SC-1 cells [33].Advances in Virology 3
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Figure 1: Predicted topology and sequence variation of the CAT-1 receptor for mouse ecotropic gammaretroviruses. (a) Putative topology
identiﬁes 14 predicted transmembrane domains. The third extracellularloop contains critical residues for receptor function (in red) and two
N-linked glycosylation sites. (b) Sequence variation in the CAT-1 third extracellular loop. At the top are three sequence variants found in
Mus with residues critical for entry in red. Virus infectivity of cells expressing these receptors is measured as the log10 titer of FFU/100μLo f
viral Env pseudotypes carrying the LacZ reporter gene; ND: not done. Consensus sites for N-glycosylation are underlined. CAT-1 sequence
variation is shown for mouse CAT-1 variants mCAT-1 (NIH 3T3), dCAT-1 (M. dunni), and minCAT-1 (M. minutoides). E-MLV-infected
Mus species M. castaneus, M. molossinus, M. spicilegus,a n dM. musculus are identical to mCAT-1 in the indicated region. Also shown are
CAT-1 sequences for virus-susceptible species hamster (ha), rat (r), and XC rat cells (xc) and for virus-resistant human (hu).
The cytopathicity of these 3 viruses is due to single
amino acid substitutions at two of the 3 amino acids that
form the receptor binding site. The cytopathicity of TR1.3
is due to W102G [33], and the cytopathicity of the other
variants is due to diﬀerent amino acid substitutions at the
same critical Env residue: S82F in Spl574, and S84A in F-
SM L V[ 45, 48]. Syncytium formation by Spl574 and F-S
MLV is accompanied by the accumulation of large amounts
of unintegrated viral DNA [48], a phenomenon which is
also a hallmark of other cytopathic retroviruses and has been
attributed to the absence of superinfection interference [53].
TR1.3 shows signiﬁcantly reduced receptor binding avidity
that correlates with its inability to block superinfection [54].
That cytopathicity is a consequence of altered receptor virus
interactions is also supported by the fact, noted above, that
MoMLV-S82F shows altered host range (Figure 1(b))a n d
also by the fact that syncytia formation by Spl574 is observed
in cells of heterologous species expressing dCAT-1, but not
mCAT-1 [49]. Thus, the cytopathicity of these 3 viruses in
cultured cells and the neurovirulence of TR1.3 are governed
by sequence diﬀerences in the viral env and, for 2 of these
viruses, by corresponding diﬀerences in the CAT-1 receptor.
Other polymorphisms of the E-MLV env can alter cell
tropism and inﬂuence disease type. The thymotropism of
radiation leukemia virus has been mapped to env [55], and
several E-MLVs have neuropathogenic properties due to env
polymorphisms. For example, TRM, a mutant variant of
the neuropathic TR1.3, induces a diﬀerent disease pathology
resultingfromreversionoftheTR1.3G102Wmutationanda
new Env mutation, S159P [56]. The most extensively studied
neuropathic E-MLV is CasBrE, an isolate from California
wild mice. Early studies mapped neurovirulence determi-
nants to the CasBrE Env [57], and recent data indicate that
CasBrE neuropathology is mediated by Env at two levels.
First, the CasBrE Env targets the virus to cells within the
CNS that express signiﬁcant levels of CAT-1, and second,
disease-associated spongiosis is induced by MLV-receptor-
independent toxicity of this Env, determinants of which4 Advances in Virology
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Figure 2: Structure of the FrMLV E-MLV Env gene. (a) Stick ﬁgure representation identiﬁes the surface (SU) and transmembrane (TM)
domains, the receptor binding domain (RBD) containing three variable regions (VRA, VRB, and VRC), and the proline-rich domain (PRD).
Green triangles mark the N-linked glycosylation sites in SU. Vertical lines identify residues with roles in entry; the three residues in red
form the binding pocket. The C-terminal segments designated C2 and loop10 have also been implicated in entry [42, 43]. (b) Surface
representation of the FrMLV RBD (PDB ID 1AOL) [36], showing the location of the binding pocket (red), additional residues involved in
entry (blue), and two N-linked glycosylation sites (green).
have not been identiﬁed but are presumably shared with
other neurovirulent MLVs [58]. Env residues have also been
implicated in the targeting of the neuropathic Friend PVC-
211 variant to brain capillary endothelial cells [31]. This
tropism is due to 2 mutations, E116G in VRA and E129K in
VRC, mutations that also alter host range and interference
properties [47, 59]. These ﬁndings indicate that speciﬁc
replacement substitutions at diﬀerent positions in the Env
of pathogenic E-MLVs can aﬀect receptor interactions, cell
tropism, disease induction, and disease type.
5. The Role of Glycosylation in
E- M L VEntryandT r o p is m
The retroviral Env is glycosylated, as are cellular proteins
involvedinentry.Manyvirusesusetheglycansoncellsurface
glycoproteins as attachment factors [60], but glycosylation
of the CAT-1 receptor is not required for virus entry.
CAT-1 continues to support virus entry after both loop
3 N-glycan sites have been removed by mutagenesis [61].
However, host cell glycans can modulate entry of some
E-MLVs. Thus, resistance of M. dunni cells to MoMLV,
resistance of NIH 3T3 cells to Spl574, and resistance of
primary rat ﬁbroblasts and hamster cells to E-MLVs are
relieved by inhibitors of glycosylation [49, 62–66]. It is not
clear whether the responsible glycoprotein is CAT-1 or other
host glycoproteins, like the secreted factor associated with
resistance to gibbon ape leukemia virus in hamster cells
[64]. There is, however, some evidence that the restriction
of E-MLV infection in rat cells may be regulated by the
glycosylation of rat CAT-1. The CAT-1 of rat XC sarcoma
cells lacks one of the glycosylation sites found in the CAT-1
gene of other rat cells (Figure 1(b)), and heterologous cells
expressing xcCAT-1 were found to be more susceptible to
MoMLV than cells expressing rCAT-1 [67].
Glycosylation of the viral Env has been associated with
altered infectivity of multiple viruses including retroviruses
such as HIV-1 [68]. MLV Envs can have up to 9 N-linked
glycans (Figure 2(a)), and while glycans are critical for the
maturation and transport of Env [69], functional roles for
the individual Env glycans are poorly deﬁned. It has been
shown that loss of MoMLV gs2 results in a virus that is
temperature sensitive in Rat2 cells, loss of gs4 produces
noninfectious virus lacking SU protein, and loss of gs7 alters
fusion and infectivity [70–73]. Removal of either of the 2
glycosylation sites in the Env RBD, gs1 and gs2, can produce
viruses restricted by M. dunni cells due to altered virus
binding to dCAT-1, although E-MLVs diﬀer in their reliance
on these glycans [74, 75]. Thus, N-linked glycans on the
viral Env are required for proper folding and can inﬂuence
the entry process, while glycans are not needed for CAT-1Advances in Virology 5
receptor processing or receptor function and have, at best,
limited ability to modulate virus entry.
6. CAT-1 andE-MLV EnvVariationin
WildMouse Species
Exposure to E-MLV gammaretroviruses occurred only
recentlyintheevolutionofMus [76].AlthoughE-MLVERVs
are found in few of the 40 Mus species, wild mice carry three
distinctive Env subtypes of E-MLVs (Figure 3). Sequence
identity in SUenv among these virus types is 70–77%. The
ﬁrst E-MLV type, the AKV E-MLVs of the laboratory mouse,
is found as ERVs in multiple inbred strains [77]. Many of
these proviruses are capable of producing infectious virus
[78], and the widely used laboratory virus strains MoMLV,
FrMLV, and Rauscher MLV are derived from AKV MLV [79]
(Figure 3). Among the wild mouse species, AKV MLV ERVs
are found in the Asian species M. molossinus and in M.
musculusofKoreaandChinabutnoteasternEurope[76,80].
AsecondE-MLVsubtypewasinitiallyidentiﬁedinCalifornia
wildmice[81,82].ProviruseswiththisCasBrEEnvtypehave
also been found in the Asian species M. castaneus, and these
virus-infected mice were likely introduced to California by
passive transport from Asia [76, 80, 83, 84]. A third E-MLV
subtype, HoMLV, was isolated from the eastern European
species M. spicilegus, but is transmitted only as an exogenous
virus [85].
The evidence indicates that these 3 E-MLV Env variants
did not coevolve with receptor polymorphisms. Sequence
comparisons indicate that the 3rd extracellular loop of the
CAT-1 gene is invariant in wild-derived mice carrying these
3 E-MLVs: M. castaneus, M. molossinus, M. spicilegus, and M.
musculus (GenBank Accession nos. JN226407–JN226410).
The only known functional variant of this receptor in mice
is dCAT-1 of M. dunni, and it is not clear if this variant arose
inmiceexposedtovirus;thesingleavailableM.dunnisample
is a cell line that does not carry E-MLV ERVs indicative
of past infections [86], and it has not been determined
if dCAT-1 is present in natural populations of M. dunni
(now termed M. terricolor) or whether it originated by
mutation in this cultured cell line. Sequence conservation
of the receptor determining region of CAT-1 in Mus is
not due to functional constraints as the third extracellular
loops of the CAT-1 (SLC7A1) genes of various non-Mus
species are quite variable (Figure 1(b)). Although E-MLVs
can use CAT-1 receptor variants in non-Mus rodents, the
replacement mutations in other mammalian species are
incompatible with receptor function, thus limiting E-MLVs
to rodents, a type of host range restriction that is not shared
by other gammaretroviruses. The absence of polymorphism
in the Mus CAT-1 gene, even in virus-infected wild mouse
populations, is consistent with the conclusion that exposure
to E-MLVs is very recent in Mus [76] and suggests that
these mice rely on alternative survival strategies to limit the
deleterious eﬀects of infection, including posttranslational
modiﬁcation of receptor function, receptor interference, or
postentry blocks in the retroviral lifecycle.
NZB-9-1 K02730
AKV J01998
MoMLV AF033811
RaMLV U94692
FrMLV X02794
HoMLV M26527
Fv4 M33884
CasBrE X57540
Figure 3: Phylogenetic tree of the Env genes of E-MLV gam-
maretroviruses. The tree includes laboratory mouse isolates FrMLV,
MoMLV, and Rauscher MLV (RaMLV), the naturally occurring
virusesAKVMLV,CasBrE,andHoMLV,andtheEnvgeneoftheFv4
restriction gene. The three related groups are bracketed. Sequences
from GenBank were aligned using ClustalW2 and used to generate
neighbour-joining trees. The X-MLV NZB-9-1 was included to root
the tree.
7. The XPR1 Receptor for XP-MLVs
Two subgroups of nonecotropic MLVs have been isolated
from laboratory mice. These viruses were originally
described as having distinct host ranges, but they use the
same receptor, XPR1. X-MLVs and P-MLVs are both capable
of infecting cells of nonrodent species, and although P-MLVs
can eﬃciently infect mouse cells, X-MLVs were initially
identiﬁed as incapable of infecting their natural hosts [2,
87, 88]. X-MLVs and P-MLVs are closely related viruses,
and sequence diﬀerences in env and LTR are responsible for
their diﬀerences in species tropism, for their nonreciprocal
interference patterns, and for the pathogenicity of P-MLVs
in mice [11, 89–92]. Although it is clear that the RBD
VRA region is the major determinant of P-MLV and X-MLV
host range [11], the critical VRA residues involved in XPR1
receptor recognition have not been identiﬁed, although 2
residues outside VRA can inﬂuence the ability of these
viruses to infect cells of other mammalian species (Figure 4)
[93]. Viruses in the XP-MLV family are highly variable in the
Env segment containing the RBD (Figure 4), and the wild
mouse viruses, CasE#1 and Cz524, show atypical host range
patterns that distinguish them from prototypical P-MLVs
and X-MLVs (Table 1)[ 16, 89, 94].
TheXPR1receptorwasoriginallydescribedinlaboratory
mice as a P-MLV susceptibility gene [14]. Subsequent
studies demonstrated that wild-mouse-derived cell lines,
SC-1 and M. dunni, are susceptible to X-MLVs as well
as P-MLVs [86, 96], while cells of the Asian species M.
castaneus are resistant to P-MLVs [15]. That a single gene
controls susceptibility to these two viruses was supported
by the equivalent chromosome map locations of the genes
controlling wild mouse susceptibility to X-MLVs and P-
MLVs and by their cross-interference [5, 15, 89, 97]. The
human and mouse Xpr1 genes were cloned [6–8] and shown
to encode a protein with 8 putative transmembrane domains
(Figure 5). While a cellular function has not been assigned
to XPR1, XPR1 is upregulated following activation of the
NF-κB RANKL-RANK signaling pathway [98] and its closest
homologues in yeast (SYG1) and plants (PHO1) function6 Advances in Virology
MEGSAFSKPLKDKINPWGPL IVMGI LVRAGASVQRDSPHQIFNVT W RVTNLMTGQTANATSLLGTMTDTFP
..S P.................I.................. V..... K I.......................
........................................ V......I.......................
........................................ V..............................
........................................ V........................... A..
WKP S S SWDL I S LKRGNT PKDQGPCYDS SV - S SGVQGAT PGGRCNPLV LE FTDAGRKA SWDAPKVW R
.
GLRLY S
................... G.... F.... G. G SI.................... K R....... T.......
................... G......... V..SI.................... K R....... A........
................................-.......................................
.................. R N........ A A...I.................... K..... G...........
.
KLYFDLCDLVGDYWDDPEPDIGDGCRTPGGRRRTRLYDFYVCPGHTVPIGCGGPGEGYCGK WGCETTGQAY
............ N............. S.... K............... L T..... R................
.................. S S.. H... S.... K... T F.......... L T..... R...............
.................--.-..... S.... K.......................................
.........I.. D..---- E T. F... S.... K. A. T F................. R............. R..
TGADPVTRFSLTRQVLNVGPRVPIGPNPVITDQLPPSQPVQIMLPRPPHPPPSGTVSMVPGAPPPSQQPGT
....... L....................... E................ R..... A A...............
.. T.... L...............................................................
.. V....................................................................
..I..............I...I.....S......... R.......... Q.S. T. A A.I---------....
XMRV
Cz524
FrMCF
XMRV
Cz524
FrMCF
XMRV
Cz524
FrMCF
XMRV
Cz524
FrMCF
VRA VRC
PRD
VRB
NZB-9-1
NZB-9-1
NZB-9-1
NZB-9-1
C a s E#1
C a s E#1
C a s E#1
C a s E#1
Figure 4: Alignment of the predicted amino acid sequences of the N-terminal portion of the Env sequences of various XP-MLVs. Included
are the prototype NZB-9-1 X-MLV, the Friend FrMCF P-MLV, the wild mouse isolates CasE#1 and Cz524, and XMRV. Green blocks identify
the three variable domains of the RBD and the PRD, and a blue block identiﬁes two residues that inﬂuence species tropism [93].
Table 1: Functional variants of the XPR1 receptor in Mus.
Infectivitya Distributionb
X-MLV P-MLV CasE#1 Cz524 Common laboratory
strains Mus Species
Xpr1n − +++ −− Most None
Xpr1sxv +++ +++ +++ +++ F / S t ,L T ,L P ,S W R ,
SJL, SIM.R, SOD1 Most
Xpr1p +++ − +++ − None M. pahari
Xpr1c ++ −−+N o n e M. castaneus
Xpr1m ++ −−− None M. musculus,
M. molossinus
aMeasured as log10 titer of FFU/100μL of viral Env pseudotypes carrying the LacZ reporter. Log10 titer: +++, >3; ++, 2-3; +, 1-2; −,0 - 1 .
bDetermined for ∼50 of the common strains of laboratory mice and ∼20 of the 40 species of Mus [17, 95].
in signal transduction and phosphate sensing and transport,
respectively [8].
8.NaturallyOccurringVariantsof
theXPR1ReceptorinMus
The genus Mus includes about 40 species, and all available
species have been screened for sequence and functional
variants of Xpr1 (Figures 5 and 6). Of the 5 sequence variants
found in wild mice, 4 show unique receptor phenotypes
based on their ability to support entry of diﬀerent virus
isolates that rely on this receptor (Table 1). The most
common receptor variant among wild mouse species was
originally termed Sxv (susceptibility to xenotropic virus)
[5]. This variant is found in many Asian species as well as
western European house mice [17, 99], and mice with Sxv
were introduced into the Americas by European immigrants
and explorers (Figure 7). Sxv is also carried by several of
the common inbred strains of laboratory mice [95]. Sxv is
the most permissive of the Xpr1 alleles and supports entry
of all XP-MLV host range variants (Table 1). The second
most geographically widespread Xpr1 allele, Xpr1m,i sf o u n d
in two house mouse species, M. musculus,w h i c hr a n g e s
from central Europe to the Paciﬁc, and M. molossinus,f o u n d
in Japan [17]. This variant is highly restrictive, allowing
ineﬃcient entry of X-MLVs, while restricting all other XP-
MLVs. A third allele, Xpr1c, is found in the southeast Asian
mouse, M. castaneus, and is responsible for resistance to
infection by P-MLVs [15, 99] .Af o u r t hw i l dm o u s eXpr1
allele is restricted to the Asian species M. pahari; these mice
are susceptible to X-MLVs and to CasE#1 [16]( Table 1).
There is a ﬁfth mouse Xpr1 variant, Xpr1n. The ﬁrst
of the receptor alleles to be identiﬁed, Xpr1n, was clonedAdvances in Virology 7
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Figure 5: Predicted topology and sequence variation of the XPR1 receptor for XP-MLVs. At the top is shown the predicted structure with
eightputativetransmembranedomainsand4extracellularloops(ECLs).Thecenterdiagramshowstherelativelocationsofthe4ECLsinthe
XPR1 protein, and the bottom shows sequence variation in the two ECLs involved in virus entry. Sequence is provided for the 5 functional
XPR1 variants in Mus, and the red arrows indicate the 6 residues involved in entry.
from NIH 3T3 laboratory mouse cells [6–8]. This variant
is responsible for the restrictive phenotype originally used
to deﬁne the “xenotropic” host range subgroup, that is,
viruses unable to infect cells of their home species [12].
Xpr1n is unusable by X-MLVs or by the 2 wild mouse virus
isolates, although it supports entry by P-MLVs (Table 1). The
origin of this laboratory mouse variant is unclear. Although
Xpr1n is carried by the majority of common inbred mouse
strains, it has not been found in any wild-trapped mouse
[17, 95]( Figure 6). The common strains of laboratory mice
were derived from colonies of fancy mice maintained by
hobbyists, and they represent a mosaic of wild mouse species
[100, 101]. Genomic analysis of multiple strains indicates
that the predominant contributor to the laboratory mouse
is M. domesticus, the western European mouse, with smaller
contributions from M. musculus and M. castaneus [101].
Although this would suggest an M. domesticus origin for the
laboratorymousereceptorallele,M.domesticusmicetrapped
in disparate locations in Europe and the Americans all carry
the permissive allele [17] suggesting that Xpr1n arose and/or
was selected in the fancy mice (Figure 7).
9. GeneticBasis of XPR1 Functional
Polymorphism
InitialstudiesonXpr1receptorfunctionfocusedonsequence
diﬀerences between the phenotypic variants identiﬁed in
NIH 3T3 cells (Xpr1n)a n dM. dunni (Xpr1sxv)[ 99]. Two
critical amino acids were identiﬁed for X-MLV entry that
lie in diﬀerent putative extracellular loops (Figure 5). The
restrictive Xpr1n carries a substitution, K500E, in its third
extracellular loop (ECL3), and a deletion, T582Δ, in the
fourth loop (ECL4). Corrective mutations at either of these
sites produce functional receptors for X-MLVs without com-
promisingP-MLVreceptorfunction[99].Subsequentstudies
on the mouse receptor showed that these 2 critical residues
are not equivalently used by the XP-MLVs, as CasE#1 can
use Xpr1n-Δ582T but not Xpr1n-E500K [16]. Mutational
analysis of other polymorphic sites in the various Mus Xpr1s
identiﬁed residues at additional sites that modulate virus
entry: ECL3 positions 500, 507, and 508 and ECL4 positions
579 and 583 (Figure 5)[ 17, 94].8 Advances in Virology
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Figure 6: Phylogenetic tree of Mus. Blue arrows indicate the
species that have acquired XP-MLV ERVs, and the subset that have
predominantly X-MLVs. 4 colored boxes identify the mice carrying
the 4 restrictive Xpr1 alleles; all other species carry the permissive
Xpr1sxv.
Although it is possible that the XPR1 protein carries two
separate receptor determinants on ECL3 and ECL4 [102],
it is more likely that the key residues in ECL3 and ECL4
form a single virus attachment site. The various viruses
that use XPR1 for entry are sensitive to mutational changes
in both ECL3 and ECL4 [16, 17, 94]( Figure 8). Thus,
P-MLVs and the wild mouse viruses CasE#1 and Cz524
show diﬀerent patterns of infectivity for Xpr1p mutants that
have substitutions in ECL3 but identical ECL4 sequences.
T h e s es a m ev i r u s e sa l s od i ﬀer in their infectivity for cells
with Xpr1m, Xpr1c, and Xpr1sxv, which have identical ECL3
sequences but diﬀerent deletions in ECL4. The involvement
ofresiduesinmultiplereceptordomainsisalsocharacteristic
of other retrovirus receptors [103]. While the diﬀerent
domains required for these other retroviral receptors can
have distinctive roles in virus attachment and entry [104,
105], this division of labor has not yet been shown to be the
case for the XPR1 ECL3 and ECL4 domains.
10. P-MLV Entry That Is Independentof
theXPR1Receptor
Although it is clear that MLV entry is typically mediated
by speciﬁc cell surface receptors, some MLVs are capable of
bypassing the need for their cognate receptors and can infect
cells that lack receptors and may also be able to infect cells in
which those receptors are downregulated by superinfection
[106, 107]. Such alternative entry mechanisms seem to be
particularly important for P-MLVs, viruses that are less
able to establish eﬀective superinfection immunity against
further infection [99, 108] either because they may have
lower binding aﬃnity for the XPR1 receptor than the X-
MLVs or because Env-bound receptors may recycle rapidly
into acidic compartments where the Env-receptor complex
is disrupted allowing the freed receptor to recycle back to the
plasma membrane. This ineﬀective or delayed establishment
of interference to exogenous infection has been linked to
the massive accumulation of viral DNA in P-MLV-infected
mice [109] and to the ability of P-MLVs to induce cytopathic
responses in mink lung cells in which superinfection induces
an ER stress response and apoptosis [4, 110, 111].
Infectious P-MLVs arise in preleukemic tissues of mice
with high levels of E-MLVs. P-MLVs have recombinant
genomes in which env sequences are derived from endoge-
nous polytropic or modiﬁed polytropic sequences, the Pmvs
or Mpmvs [112]. The Pmv and Mpmv proviruses that give
rise to these recombinants have not been shown to be
capable of producing infectious virus directly [113], but
transmission of these ERVs and recombinant infectious P-
MLVs can be accomplished through several mechanisms
that are independent of XPR1. First, P-MLVs are generally
transmitted in viremic mice as pseudotypes of E-MLVs and
thus use mCAT-1 for entry [114, 115]. Also, homodimers
representing the transcribed products of Mpmv and Pmv
proviruses can be packaged into E-MLV virions, and these
“mobilized” proviruses can infect cells, replicate in those
new cells, and spread to other cells as pseudotyped virus
[116]. Another transmission mechanism allows infectious,
recombinant P-MLVs to use alternative receptors in the
presence of the soluble RBD glycoprotein for that receptor.
P-MLVs and entry defective E-MLVs, but not X-MLVs, can
be “transactivated” in this way by E-MLV RBD [38, 108].
This transactivation process is controlled, at least in part, by
the conserved Env residue H8 and has also been described
for other viruses such as feline leukemia viruses [117]. While
these mechanisms provide alternative routes for P-MLV
transmission that are independent of the receptor, it should
be noted that interference with the XPR1 receptor protects
mice from P-MLV-induced disease [118] highlighting the
crucial role of XPR1-mediated entry in the disease process.
11. Coevolution of XPR1 andXP-MLVs in Mus
The species distribution of the Mus XPR1 variants indi-
cates that polymorphic, virus-restrictive receptors appeared
when mice were exposed to XP-MLVs, especially X-MLVs
(Figure 6). For most of the 8 million years of Mus evolution,
species carried the permissive Xpr1sxv allele. Mice were
subjected to XP-MLV infection about 0.5MYA, and this
exposure is marked by the acquisition of MLV ERVs in the
4 house mouse species [76, 119, 120]. M. domesticus carries
P-MLV ERVs, whereas M. castaneus, M. musculus, and M.
molossinus carry predominantly X-MLVs [76]. The common
laboratory mouse strains, which are mosaics of these wild
mouse species, generally carry multiple copies of X-MLVsAdvances in Virology 9
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and P-MLVs [121, 122]. The acquisition of these germline
ERVs, and speciﬁcally X-MLVs, roughly coincides with the
appearance of restrictive Xpr1 alleles: Xpr1c in M. castaneus,
Xpr1m in M. molossinus and M. musculus,a n dXpr1n in
laboratorymice(Figure 6).Eachoftheserestrictivereceptors
carries a unique deletion in the XPR1 ECL4 (Figure 5)[ 17].
M. domesticus, the species carrying only inactive P-MLV
ERVs, maintains the full-length, permissive Xpr1sxv receptor
common to ancestral species of Mus. The fact that restrictive
receptors have evolved in X-MLV infected mice suggests
that this host pathogen interface has been an important
evolutionary battleground. This also suggests that X-MLV
infection is deleterious for mice, although the consequences
of X-MLV infection have not yet been described because
mouse gammaretroviruses have been studied largely in X-
MLV-resistant laboratory mice. The discovery of mouse
species and strains with XPR1 variants that eﬃciently
support X-MLV entry now provides the basis for studies on
pathogenesis of these viruses, and such studies have now
been initiated [123].
12. CAT-1 and XPR1 Receptor Downregulation
by EnvGlycoproteinsinMus
Virusentrycanbeinhibitedbyreceptormutantsbutcanalso
be blocked by members of a second set of genes found in E-
MLV-orX-MLV-infectedwildmice.Thisfamilyofresistance
genes governs production of MLV Env glycoproteins that are
thoughttorestrictvirusthroughreceptorinterference.These
genesincludeFv4,whichblocksE-MLVs[124],andthegenes
Rmcf and Rmcf2 which restrict XP-MLVs and, in the case of
Rmcf, inhibit P-MLV-induced disease [118, 124–126]. There
is also evidence suggesting that additional Rmcf-like XPR1
receptor blocking genes are present in M. castaneus [127].
Speciﬁc ERVs have been mapped to 3 of these resistance
genes, all of which are defective for virus production but
have intact env genes. Fv4 is a truncated provirus, Rmcf has
a major deletion spanning gag-pol [124, 128], and Rmcf2 has
a stop codon that prematurely terminates integrase [125]. It
has been proposed that the products of Fv4,Rcmf,an dRcmf2
reduce or downregulate activity of their cognate receptors,
and Fv4 also has a defect in the fusion peptide of TMenv,s o10 Advances in Virology
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incorporation of this Env into virions in virus-infected cells
results in their reduced infectivity [129].
Interference genes that target both host range types are
found in the Asian species M. castaneus, mice that are
infected with X-MLVs as well as with E-MLVs that are
related to the leukemogenic and neuropathic CasBrE E-MLV
[76, 80, 130]. These mice rely on several survival strategies to
mitigate the consequences of infection. In addition to their
restrictive Xpr1c receptor, these mice carry Fv4 as well as
Rmcf-type XP-MLV interference genes. These interference
genes likely arose in this species [80, 125]; CasBrE and Fv4
have related Env genes (Figure 3)[ 130]. Transmission into
other gene pools can proceed quickly for invasive genes
like retrotransposons and for virus restriction genes that
provide an immediate survival advantage. While the number
and geographic distribution of Rmcf-type genes in Asian
mice is not known, Fv4 is found in AKV MLV-infected
mice trapped in Japan (M. molossinus) a n di nK o r e a[ 80].
CasBrE and Fv4 are both found in California mice, where
Asian mice were likely introduced by the shipping trade
[76, 82, 131]. The discovery of multiple interfering loci in
infected mouse species and their geographic spread suggests
that these coopted Env genes represent an eﬀective survival
mechanism. The general importance of this form of innate
immunity is also illustrated by the fact that Env genes
with similar antiviral functions have also been identiﬁed in
chickens, sheep, and cats [132–134].
13. XPR1 Receptor Polymorphism and Entry
PhenotypesinNon-Mus Species
The XP-MLVs are capable of infecting cells of other species,
includinghumans(Figure 9).Cellsofnearlyallmammalsare
permissive to infection by X-MLVs, whereas a subset of these
species is also susceptible to P-MLVs. This suggests that X-
MLVshavelessstringentreceptorrequirementsthanP-MLVs
[17, 87, 88]. Some mammalian species show distinctive pat-
terns of virus susceptibility not found in mice, for example,
the restriction of P-MLVs and both wild mouse XP-MLVs by
dog and buﬀalo cells (Figure 9)[ 17]. Analysis of mammalian
XPR1 genes reveals signiﬁcant sequence variability especially
in the receptor determining ECL4, although this 13 residue
segment contains 3 nonvariant residues, S578, T580, and
G589. These conserved residues do not contribute to the
receptor attachment site [17]. Further analysis of these
functionally distinctive XPR1 genes may provide insight into
the factors that facilitate transspecies transmission.
14. XMRV
Mice are important vectors of diseases that infect humans
and their livestock [135], and MLV-infected house mouse
species have a worldwide geographic distribution [136]. The
horizontal transfer of infectious MLVs between individuals
has been documented in wild mouse populations and in
laboratory mice [82, 137], and MLV-related viral sequences,
proteins, and antibodies have been reported in human blood
donors and patients with prostate cancer and chronic fatigue
syndrome [138–140]. An infectious virus ﬁrst identiﬁed
in prostate cancer patients, termed XMRV (xenotropic
murine leukemia virus-related virus), shows close sequence
homology with XP-MLVs [141], uses the XPR1 receptor
[138], and has xenotropic host range [94]. Although XMRV
origin by transspecies transmission is consistent with the
evidence of MLV transmission between mice and evidence
of transmission of mouse C-type viruses to other species
[142–144], several recent studies on XMRV have implicated
laboratory contamination [145–148]. Additional studies
aiming to resolve the origins issue are focused on patient
samples and the characterization of mice for XMRV-related
sequences [149].
It is clear that XMRV diﬀers from MLVs isolated from
mice in several biological properties, including host range
and receptor usage. The two critical residues for X-MLV
entry in Mus XPR1, K500 and T582 [99], independently
produce equivalent receptor determinants for X-MLV but
not for XMRV [17] or for the wild mouse isolate CasE#1
[16]. While T582 but not K500 is required for CasE#1,
XMRV preferentially relies on K500 [16, 17]. XMRV also
diﬀers from XP-MLVs in its ability to infect cells of diﬀerent
mammalian species. Although X-MLVs are able to infect all
mammals, XMRV is uniquely restricted by cells of 3 species:
Chinese hamster, Syrian hamster, and gerbil (Figure 9). For
gerbil, this diﬀerence is likely attributable to XPR1 receptor
polymorphism, as expression of the gerbil XPR1 receptor
in heterologous cells reproduced the gerbil susceptibility
pattern [17]. The restriction of XMRV in Syrian hamster
BHK cells may involve other host factors. Expression ofAdvances in Virology 11
human Xpr1 in these cells resulted in susceptibility to X-
MLV but not XMRV, and analysis of interspecies somatic
cell hybrids suggested that BHK cells lack a secondary factor
needed for XMRV infection [150]. These results suggest
that XMRV diﬀers from other X-MLVs in its interaction
with XPR1 receptor determinants and also suggest that
XMRV may be uniquely dependent on an as yet unidentiﬁed
receptorcofactor.Furtherstudieswiththisvirusmayprovide
additional insight into xenotropism and the interactions and
identity of viral and host proteins that direct entry.
15. Conclusions
Retrovirus entry is dependent on the presence and accessi-
bility of speciﬁc cell surface receptors. Mutational changes
in these receptors and in the receptor attachment sites in
the virus Env can alter the very ﬁrst step in the virus life
cycle and can thus have profound consequences for virus
replication. Inhibition of virus entry has been a particularly
eﬀe c t i v ea n t i vi ra lt a c t i ci nm i c ei n f e c t e dwi t hM L V sa sw e l la s
with other gammaretroviruses [151]. Entry is also the target
of host restrictions in other species subject to retrovirus
infection as shown by the discovery of interfering ERV
Envs in multiple species [132–134] and by the discovery of
inhibitory mutations in other receptors, such as the HIV-1
CCR5 coreceptor [152].
For the laboratory mouse MLVs, alterations in host
receptors and/or virus Env can result in virus restriction, can
alterthetypeandtempoofinfection-inducedpathology,and
may also inﬂuence postentry events [153]. The interacting
sites of these receptors and Env are highly polymorphic, as
expected for coevolving entities in an “arms race” driven
by sequential reciprocal adaptations. For the XP-MLVs and
XMRV, the battleground at the cell surface has produced
5 functionally distinct receptors in mice and more than a
half dozen distinctive host range virus variants, variants that
interact with diﬀerent but overlapping sets of determinants
on the XPR1 receptor or rely on alternative mechanisms of
transmission independent of XPR1. For the E-MLVs, CAT-
1 shows more limited variation although multiple viral Env
subtypeshaveevolved.Theinteractinginterfacesofvirusand
host proteins are targeted not just by mutational changes but
also by epigenetic modiﬁcations resulting from glycosylation
and by a host defensive strategy that relies on co-option
of germline env genes to interfere with virus infection.
There is also evidence of additional host factors or co-
factorsthatinﬂuenceentryofthemousegammaretroviruses,
some of which are aﬀected by glycosylation [150, 154].
Future studies on the mouse gammaretroviruses should
identifyotherhostfactorsinvolvedinentryandtrans-species
transmission, should describe the consequences of X-MLV
infection in mice permissive to the “xenotropic” viruses, and
should further illuminate the coevolutionary paths of these
pathogens and their hosts.
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